Table 4.

Univariate survival analysis for patients with stage III and IV ovarian cancers

VariablesNo. patients (no. death)Median survival (y)HR (95% CI)P
APM component markers
    All (−)15 (14)1.444.12 (2.06-8.23)<0.01
    1-4 (+/−) or (+)87 (64)2.291.92 (1.17-3.15)0.01
    All (+/−) or (+)35 (22)4.58
IT CD3+/CD8+ T cells
    Absent40 (33)1.522.11 (1.39-3.22)<0.01
    Present97 (67)3.37
PT CD3+/CD8+ T cells
    Absent12 (12)1.852.26 (1.23-4.16)0.01
    Present125 (88)2.83
Grade
    High131 (96)2.581.82 (0.66-4.97)0.25
    Low6 (4)5.39
Histology
    Serous112 (81)2.581.34 (0.81-2.23)0.25
    Nonserous25 (19)3.42
Cytoreduction
    Suboptimal60 (54)1.542.43 (1.63-3.64)<0.01
    Optimal77 (46)3.37